No significant difference in TIMP-1 levels between low/moderate-grade and high-grade/invasive IPMN; no significant difference in the urinary expression of LYVE-1 and PGEM between PC, IPMN, and healthy controls. The gene discussed is LYVE1; the disease is pancreatic intraductal papillary-mucinous neoplasm.